The risk of hospitalization for motor vehicle accident injury in narcolepsy and the benefits of stimulant use: A nationwide cohort study in Taiwan

Nian Sheng Tzeng, Shih Chun Hsing, Chi Hsiang Chung, Hsin An Chang, Yu Chen Kao, Wei Chung Mao, Cheryl C.H. Yang, Terry B.J. Kuo, Tien Yu Chen, Wu Chien Chien

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Study Objectives: To examine the risk of hospitalization for motor vehicle accident injury (MVAI) in patients with narcolepsy and the effects of stimulant use on MVAI occurrence in patients with narcolepsy. Methods: This is a population-based, retrospective cohort study using Taiwan’s National Health Insurance Research Database between 2000 and 2013. We included patients with narcolepsy based on the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes, 347. The case and matched control participants were selected in a ratio of 1:3, and the traffic accident (ICD-9-CM codes: E810–E819) plus injury codes (ICD-9-CM codes: 800.xx–999.xx) due to MVAI following hospitalization were used for the study outcome. The type of injury, causes, intentionality, and the effects of stimulant use on patients with narcolepsy were also assessed. Results: A total of 1,316 participants were enrolled, including 329 participants with narcolepsy and 987 participants without narcolepsy. During a 14-year follow-up period, a total of 104 participants had MVAI, of whom 47 (1,559.54 per 100,000 person-years) belonged to the narcolepsy cohort and 57 (556.21 per 100,000 person-years) to the non-narcolepsy cohort. After adjusting for covariates, the risk of hospitalization for MVAI among participants with narcolepsy was still significantly higher than those without narcolepsy (adjusted hazard ratio = 6.725; 95% confidence interval = 4.421–10.231; P < .001). The use of modafinil or methylphenidate, as monotherapy or combined treatment, was associated with a lower risk of MVAI in the narcolepsy cohort. Conclusions: Patients with narcolepsy may have a higher risk of hospitalization for MVAI and stimulant use could mitigate such risk.

Original languageEnglish
Pages (from-to)881-889
Number of pages9
JournalJournal of Clinical Sleep Medicine
Volume15
Issue number6
DOIs
Publication statusPublished - Jan 1 2019
Externally publishedYes

Fingerprint

Narcolepsy
Motor Vehicles
Taiwan
Accidents
Hospitalization
Cohort Studies
Wounds and Injuries
International Classification of Diseases
Methylphenidate
Traffic Accidents
National Health Programs
Retrospective Studies
Outcome Assessment (Health Care)
Databases

Keywords

  • Methylphenidate
  • Modafinil
  • Motor vehicle accident injury
  • Narcolepsy

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Neurology
  • Clinical Neurology

Cite this

The risk of hospitalization for motor vehicle accident injury in narcolepsy and the benefits of stimulant use : A nationwide cohort study in Taiwan. / Tzeng, Nian Sheng; Hsing, Shih Chun; Chung, Chi Hsiang; Chang, Hsin An; Kao, Yu Chen; Mao, Wei Chung; Yang, Cheryl C.H.; Kuo, Terry B.J.; Chen, Tien Yu; Chien, Wu Chien.

In: Journal of Clinical Sleep Medicine, Vol. 15, No. 6, 01.01.2019, p. 881-889.

Research output: Contribution to journalArticle

Tzeng, Nian Sheng ; Hsing, Shih Chun ; Chung, Chi Hsiang ; Chang, Hsin An ; Kao, Yu Chen ; Mao, Wei Chung ; Yang, Cheryl C.H. ; Kuo, Terry B.J. ; Chen, Tien Yu ; Chien, Wu Chien. / The risk of hospitalization for motor vehicle accident injury in narcolepsy and the benefits of stimulant use : A nationwide cohort study in Taiwan. In: Journal of Clinical Sleep Medicine. 2019 ; Vol. 15, No. 6. pp. 881-889.
@article{7c2c62d453de49349611a1eecb7f95e4,
title = "The risk of hospitalization for motor vehicle accident injury in narcolepsy and the benefits of stimulant use: A nationwide cohort study in Taiwan",
abstract = "Study Objectives: To examine the risk of hospitalization for motor vehicle accident injury (MVAI) in patients with narcolepsy and the effects of stimulant use on MVAI occurrence in patients with narcolepsy. Methods: This is a population-based, retrospective cohort study using Taiwan’s National Health Insurance Research Database between 2000 and 2013. We included patients with narcolepsy based on the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes, 347. The case and matched control participants were selected in a ratio of 1:3, and the traffic accident (ICD-9-CM codes: E810–E819) plus injury codes (ICD-9-CM codes: 800.xx–999.xx) due to MVAI following hospitalization were used for the study outcome. The type of injury, causes, intentionality, and the effects of stimulant use on patients with narcolepsy were also assessed. Results: A total of 1,316 participants were enrolled, including 329 participants with narcolepsy and 987 participants without narcolepsy. During a 14-year follow-up period, a total of 104 participants had MVAI, of whom 47 (1,559.54 per 100,000 person-years) belonged to the narcolepsy cohort and 57 (556.21 per 100,000 person-years) to the non-narcolepsy cohort. After adjusting for covariates, the risk of hospitalization for MVAI among participants with narcolepsy was still significantly higher than those without narcolepsy (adjusted hazard ratio = 6.725; 95{\%} confidence interval = 4.421–10.231; P < .001). The use of modafinil or methylphenidate, as monotherapy or combined treatment, was associated with a lower risk of MVAI in the narcolepsy cohort. Conclusions: Patients with narcolepsy may have a higher risk of hospitalization for MVAI and stimulant use could mitigate such risk.",
keywords = "Methylphenidate, Modafinil, Motor vehicle accident injury, Narcolepsy",
author = "Tzeng, {Nian Sheng} and Hsing, {Shih Chun} and Chung, {Chi Hsiang} and Chang, {Hsin An} and Kao, {Yu Chen} and Mao, {Wei Chung} and Yang, {Cheryl C.H.} and Kuo, {Terry B.J.} and Chen, {Tien Yu} and Chien, {Wu Chien}",
year = "2019",
month = "1",
day = "1",
doi = "10.5664/jcsm.7842",
language = "English",
volume = "15",
pages = "881--889",
journal = "Journal of Clinical Sleep Medicine",
issn = "1550-9389",
publisher = "American Academy of Sleep Medicine",
number = "6",

}

TY - JOUR

T1 - The risk of hospitalization for motor vehicle accident injury in narcolepsy and the benefits of stimulant use

T2 - A nationwide cohort study in Taiwan

AU - Tzeng, Nian Sheng

AU - Hsing, Shih Chun

AU - Chung, Chi Hsiang

AU - Chang, Hsin An

AU - Kao, Yu Chen

AU - Mao, Wei Chung

AU - Yang, Cheryl C.H.

AU - Kuo, Terry B.J.

AU - Chen, Tien Yu

AU - Chien, Wu Chien

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Study Objectives: To examine the risk of hospitalization for motor vehicle accident injury (MVAI) in patients with narcolepsy and the effects of stimulant use on MVAI occurrence in patients with narcolepsy. Methods: This is a population-based, retrospective cohort study using Taiwan’s National Health Insurance Research Database between 2000 and 2013. We included patients with narcolepsy based on the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes, 347. The case and matched control participants were selected in a ratio of 1:3, and the traffic accident (ICD-9-CM codes: E810–E819) plus injury codes (ICD-9-CM codes: 800.xx–999.xx) due to MVAI following hospitalization were used for the study outcome. The type of injury, causes, intentionality, and the effects of stimulant use on patients with narcolepsy were also assessed. Results: A total of 1,316 participants were enrolled, including 329 participants with narcolepsy and 987 participants without narcolepsy. During a 14-year follow-up period, a total of 104 participants had MVAI, of whom 47 (1,559.54 per 100,000 person-years) belonged to the narcolepsy cohort and 57 (556.21 per 100,000 person-years) to the non-narcolepsy cohort. After adjusting for covariates, the risk of hospitalization for MVAI among participants with narcolepsy was still significantly higher than those without narcolepsy (adjusted hazard ratio = 6.725; 95% confidence interval = 4.421–10.231; P < .001). The use of modafinil or methylphenidate, as monotherapy or combined treatment, was associated with a lower risk of MVAI in the narcolepsy cohort. Conclusions: Patients with narcolepsy may have a higher risk of hospitalization for MVAI and stimulant use could mitigate such risk.

AB - Study Objectives: To examine the risk of hospitalization for motor vehicle accident injury (MVAI) in patients with narcolepsy and the effects of stimulant use on MVAI occurrence in patients with narcolepsy. Methods: This is a population-based, retrospective cohort study using Taiwan’s National Health Insurance Research Database between 2000 and 2013. We included patients with narcolepsy based on the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes, 347. The case and matched control participants were selected in a ratio of 1:3, and the traffic accident (ICD-9-CM codes: E810–E819) plus injury codes (ICD-9-CM codes: 800.xx–999.xx) due to MVAI following hospitalization were used for the study outcome. The type of injury, causes, intentionality, and the effects of stimulant use on patients with narcolepsy were also assessed. Results: A total of 1,316 participants were enrolled, including 329 participants with narcolepsy and 987 participants without narcolepsy. During a 14-year follow-up period, a total of 104 participants had MVAI, of whom 47 (1,559.54 per 100,000 person-years) belonged to the narcolepsy cohort and 57 (556.21 per 100,000 person-years) to the non-narcolepsy cohort. After adjusting for covariates, the risk of hospitalization for MVAI among participants with narcolepsy was still significantly higher than those without narcolepsy (adjusted hazard ratio = 6.725; 95% confidence interval = 4.421–10.231; P < .001). The use of modafinil or methylphenidate, as monotherapy or combined treatment, was associated with a lower risk of MVAI in the narcolepsy cohort. Conclusions: Patients with narcolepsy may have a higher risk of hospitalization for MVAI and stimulant use could mitigate such risk.

KW - Methylphenidate

KW - Modafinil

KW - Motor vehicle accident injury

KW - Narcolepsy

UR - http://www.scopus.com/inward/record.url?scp=85068488356&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068488356&partnerID=8YFLogxK

U2 - 10.5664/jcsm.7842

DO - 10.5664/jcsm.7842

M3 - Article

C2 - 31138389

AN - SCOPUS:85068488356

VL - 15

SP - 881

EP - 889

JO - Journal of Clinical Sleep Medicine

JF - Journal of Clinical Sleep Medicine

SN - 1550-9389

IS - 6

ER -